Rotella Capital Management’s Enzo Biochem, Inc. ENZ Stock Holding History

Rotella Capital Management’s Portfolio ENZ Stock Details ENZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-39,122	Closed	-$176K	–	249
2015 Q4	$176K	Buy	+39,122	New	+$165K	0.16%	241
2015 Q2	–	Sell	-13,434	Closed	-$40K	–	586
2015 Q1	$40K	Sell	13,434 -224	-2%	-$733	0.03%	466
2014 Q4	$61K	Buy	13,658 +1,800	+15%	+$8.58K	0.05%	285
2014 Q3	$61K	Buy	+11,858	New	+$63.3K	0.06%	227
2014 Q2	–	Sell	-15,516	Closed	-$65K	–	420
2014 Q1	$65K	Buy	+15,516	New	+$53.2K	0.08%	150

Other funds holding ENZ

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

LSVM

Lone Star Value Management Old Greenwich, Connecticut $52.7M AUM 30.18% 1-Year Est. Return

Rotella Capital Management's ENZ Position: Q1 2016 in Review

Rotella Capital Management sold out of Enzo Biochem, Inc. (ENZ) in Q1 2016, closing a stake of 39,122 shares — an estimated $176K sold.

Rotella Capital Management first reported a position in ENZ in Q1 2014 and held it in 5 quarters. The position peaked at $176K in Q4 2015. 99 funds tracked by Wall St. Rank hold ENZ as of Q1 2016.

Rotella Capital Management reported no remaining Enzo Biochem, Inc. position as of Q1 2016 after selling out during the quarter.
Rotella Capital Management sold 39,122 Enzo Biochem, Inc. shares in Q1 2016, an estimated $176K.
Rotella Capital Management first reported a position in Enzo Biochem, Inc. in Q1 2014 and held it in 5 quarters.
Rotella Capital Management's Enzo Biochem, Inc. position peaked at $176K in Q4 2015.
99 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q1 2016.

Based on Rotella Capital Management's 13F filing for Q1 2016, filed 13 May 2016.